A Phase 2/3 interventional study of Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine in Pain Management After Functional Endoscopic Sinuscopy, sponsored by South Egypt Cancer Institute. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-04-29.
Sponsored by South Egypt Cancer Institute · Phase 2/3, Interventional, and Supportive care
Among 299 studies in Pain with a site in Egypt — 64 open to participants now, 79 under way, 5 of them phase 3. Pain · Egypt.
Among the 299 studies in Pain with a site in Egypt, this one is the 278th largest by planned enrollment of the 285 interventional ones that give a count, is one of 26 that started in 2026, is one of 12 in phase 2/3, reaches primary completion later than 59 of the 78 other live ones, and was the 278th registered.
10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.
Browse Pain studies →64 of the 299 studies in Pain with a site in Egypt are open now. Recruiting first, the newest first:
Tanta University · Sites in Egypt
Tanta University · Sites in Egypt
Tanta University · Sites in Egypt
Menoufia University · Sites in Egypt
Cairo University · Sites in Egypt
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
299 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 20 · Phase 2 41 · Phase 3 29 · Phase 4 25
First in 2007; this study’s year is marked. 26 started in 2026.
This study's planned enrollment of 20 is below the median of 66 across 8,493 interventional studies indexed under Pain.
Median enrollment 62 across the 285 interventional studies, 40 across the 13 observational. Of the 182 that completed or were terminated, 2 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 299 have an industry lead sponsor. The 10 most frequent:
South Egypt Cancer Institute is the lead sponsor of 35 studies on the registry; 7 are open to participants now.
South Egypt Cancer Institute has 3 studies filed under Pain — fewer than ten, so there is no comparison to draw.
15 of the studies in Pain with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07631416Sohag UniversityLumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia | 2026-11-28 |
| NCT07773376Reem MohamedWarm Versus Room Temperature Saline as a Uterine Distension Medium for Pain Reduction in Women Undergoing Outpatient Hysteroscopy: Protocol for a Randomized Controlled Trial | 2026-12 |
| NCT07485517Menoufia UniversityDeep Versus Moderate Neuromuscular Blocking | 2026-12-01 |
| NCT07593300Misr University for Science and TechnologyRISS Versus Lower Thoracic ESP Block for Analgesia After Laparoscopic Abdominal Surgery: A Randomized Trial | 2026-12-31 |
| NCT07835191British University In EgyptEfficacy of Pre-cooling and Sweet-tasting Solution on Pain Related to Local Anesthesia Injection in Children | 2027-01 |
Among the 299 studies in Pain with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Improving postoperative analgesia after functional endoscopic surgery: Sphenopalatine ganglion block versus soaked nasal packing using bupivacaine and dexmedetomidine
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Drug: Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Drug: Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
effectiveness of SPGB with bupivacaine and dexmedetomidine for postoperative analgesia
Numeric rating scale for pain will be assessed and recorded within the first 24 hours where 1 means the worst pain and 10 means no pain. Total rescue analgesia in 24 H when Numeric rating scale ≥ 4 was recorded and the first time when it was given will be recorded.
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Apr 2026; primary completion for Oct 2026, 6 months later.
Of 35 non-industry phase 2/3 interventional studies under Pain, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 6 months is below that.
Counting every sponsor, half of 41 studies reached it within 20 months; a quarter within 13 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
South Egypt Cancer Institute